Skip to Main Content
Welcome to the Scientist.com Marketplace

Go to Main Navigation

DOPPL SA

Start a request
Year Established:
2022
Website:
doppl.ch
Headquarters:
Lausanne, VD, CH
Company Type:
Small Business (1-10M TTM Revenue)
Completed Requests:
10
Open Requests:
6

DOPPL – Disrupting healthcare with our high resolution, automated organoid factory

Exploiting the power of bioengineered technologies, DOPPL is the leading platform for high-throughput organoid culture and screenings for many tissue types and multiple phenotypic readouts. The DOPPL platform features a large cohort of organoid models and their associated data in a biobank, automated workflows for unlimited organoid expansion and use in large scale screens, and imaging capabilities. DOPPL engages in partnered projects for novel in vitro model generation and screening in drug development. Applications include patient-specific targeted therapy screening in cancer organoids, novel T-cell killing assay methodologies for immuno-oncology studies, toxicity assessment and transport studies on gastrointestinal organoids, and on organoid-based blood-brain barrier model.

Site Badges
DOPPL SA
EPFL Innovation Park Lausanne, VD, 1015 Switzerland
DOPPL SA
EPFL Innovation Park Lausanne, VD, 1015 Switzerland

Get started

If your organization has a Scientist.com marketplace, you can log in here to order products and services directly.

If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here.

To order products instantly, request access below.

Password must:

• Be at least 12 characters in length

• Contain a lowercase letter (a-z)

• Contain an uppercase letter (A-Z)

• Contain a numeral (0-9)

• Contain a special character (%, $, !, @)

By signing up for this account you agree to the Terms of Service